PharmaLegacy
PrivateLast Round
M&A
Jan 13, 2026
Est. Valuation
$202M
Total Funding Raised
$100M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PharmaLegacy is a life sciences company that operates as a preclinical contract research organization providing pharmacology services to pharmaceutical and biotech companies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharmaLegacy Comparables
Compare PharmaLegacy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ICE Bioscience | 81% | |
| HuaTeng Biotechnology | 81% | |
| ZSHK Laboratories Limited | 78% |
PharmaLegacy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jan 13, 2026 | ||||
| Series B Extension | Oct 22, 2021 | ||||
| Series B | Feb 1, 2021 | ||||
| Series A Extension | Feb 2, 2019 | ||||
| Series A | Feb 1, 2017 |
PharmaLegacy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CICC Capital | Series B |
| Suzhou Guofa Venture Capital | Series B Extension |
| HongShan Capital Group (HSG) | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2026
$202M round led by Shanghai OPM Biosciences
- Mar 23, 2025
Monthly visitors grew 621% MoM, reaching 10.1K.
PharmaLegacy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PharmaLegacy's valuation, stock price, and market status.
Is PharmaLegacy a public or private company?
PharmaLegacy is a private company.
What is the current stock price of PharmaLegacy?
PharmaLegacy is a private company, so its shares have no public market price. Caplight tracks PharmaLegacy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PharmaLegacy worth (valuation)?
PharmaLegacy's valuation is estimated at $202.0M based on funding round data.
Can I buy PharmaLegacy stock?
PharmaLegacy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PharmaLegacy's last funding round?
PharmaLegacy's most recent funding round was M&A on January 13, 2026.
Who are the main investors in PharmaLegacy?
Key investors in PharmaLegacy include HongShan Capital Group (HSG).
Will PharmaLegacy IPO soon?
No public IPO plans have been announced for PharmaLegacy.
How can I track PharmaLegacy secondary market activity?
Caplight tracks bids, offers, and trades in PharmaLegacy's shares on secondary markets.